Target intelligence / Profile preview

Serotonin 5-hydroxytryptamine receptor 3 subunit (5-HT3 receptor subunit)

Target
5-HT3 receptor subunit
Molecular classification
Ion channel, Ligand-gated ion channel, Cys-loop receptor, Receptor
01

Overview

The serotonin 5-hydroxytryptamine receptor 3 (5-HT3) subunit refers to the gene products that constitute the functional 5-HT3 receptor, an ionotropic receptor and cation-selective ligand-gated ion channel of the Cys-loop superfamily[1][2][5]. A functional receptor is formed as a pentameric complex of five subunits, most often identical (homopentameric, typically 5-HT3A) or as heteropentamers (5-HT3A with 5-HT3B-E subunits)[1][2]. These receptor subunits are expressed in both the central and peripheral nervous systems, mediating fast excitatory synaptic transmission and neuronal depolarization in response to serotonin binding[1][2][5][7]. Clinically, 5-HT3 receptor antagonists are widely employed to prevent chemotherapy-induced or postoperative nausea and vomiting, and in treatment of irritable bowel syndrome with diarrhea[4][5]. Subunit composition affects functional properties such as ion selectivity and pharmacology[2][6]. Variants in HTR3A and HTR3B genes may influence individual responses and risk for certain neuropsychiatric disorders[3][5]. **Critical notes:** - The query "Serotonin receptor 5HT3 subunit" is not a canonical target name, but rather refers generically to several different protein subunits (5-HT3A, 5-HT3B, 5-HT3C, 5-HT3D, 5-HT3E), all of which must be specified for structured or pharmacological purposes. - The canonical therapeutic target is the full "Serotonin 5-hydroxytryptamine receptor 3" (5-HT3 receptor), not an individual subunit. - Use of "subunit" without specification is ambiguous and incomplete for database or therapeutic reference[2][5]. **Clarification**: - For structured target information and most pharmacological databases, it is advisable to use "Serotonin 5-hydroxytryptamine receptor 3" or specify the subunit type (e.g., 5-HT3A subunit, 5-HT3B subunit)[1][2][5]. - Therefore, "is_incorrect" is TRUE for the queried form, as it does not specify which subunit and is not the correct canonical form for a therapeutic target.

Other names
5-HT3 subunit5-HT3A5-HT3B5-HT3C5-HT3D5-HT3EHTR3AHTR3BHTR3CHTR3DHTR3E
02

Mechanism of action

Antagonism (5-HT3 receptor antagonists block serotonin binding to reduce emetic signaling and neural excitation), Agonism (less common, used in research), Allosteric modulation

03

Biological functions

Signal transductionFast synaptic transmissionNeuronal excitationModulation of neurotransmitter release
04

Disease associations

Nausea and vomitingIrritable bowel syndromeAnxiety disordersEmesis secondary to chemotherapyOther neuropsychiatric and gastrointestinal disorders
05

Safety considerations

QT interval prolongationSerotonin syndrome (with other serotonergic drugs)Constipation (especially with alosetron)Potential for ischemic colitis (alosetron)Central nervous system effects (e.g., headache, dizziness)
06

Interacting drugs

Ondansetron

7 more in the full profile.

07

Biomarkers

Polymorphisms in HTR3A and HTR3B subunits (associated with clinical response and disease risk)5-HT3 receptor subunit expression

Beyond the preview

Go deeper on Serotonin 5-hydroxytryptamine receptor 3 subunit (5-HT3 receptor subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serotonin 5-hydroxytryptamine receptor 3 subunit (5-HT3 receptor subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call